Combined Holdings of RPTX in All ARK ETFs
Repare Therapeutics
Repare Therapeutics is a biotechnology company that focuses on developing precision oncology drugs by utilizing a proprietary genome-wide, CRISPR-enabled platform to identify synthetic lethal gene pairs in cancer. The company generates revenue through partnerships and licensing agreements with pharmaceutical companies, as well as potential future sales of its proprietary drugs under development.
Trades of RPTX in All Ark ETFs
The ten most recent trades of Repare Therapeutics in all the Ark ETFs ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Dec 03, 2024 | Sell | $55,524 | 0.85% | 0.00% |
| Nov 29, 2024 | Sell | $17,928 | 0.27% | 0.00% |
| Nov 27, 2024 | Sell | $73,395 | 1.12% | 0.01% |
| Nov 26, 2024 | Sell | $46,169 | 0.72% | 0.00% |
| Nov 25, 2024 | Sell | $77,488 | 1.26% | 0.01% |
| Nov 22, 2024 | Sell | $14,762 | 0.24% | 0.00% |
| Nov 20, 2024 | Sell | $5,441 | 0.09% | 0.00% |
| Nov 19, 2024 | Sell | $13,507 | 0.22% | 0.00% |
| Nov 13, 2024 | Sell | $8,085 | 0.11% | 0.00% |
| Nov 12, 2024 | Sell | $289 | 0.00% | 0.00% |